Biologic Drugs With Established Pharmaceutical Class: Inactivated Hepatitis B Virus Vaccine
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Inactivated Hepatitis B Virus Vaccine
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | RECOMBIVAX, RECOMBIVAX HB | hepatitis b vaccine (recombinant) | Injection | 101066 | 1986-07-23 | ⤷ Subscribe | ⤷ Subscribe |
Dynavax Technologies Corporation | HEPLISAV-B | hepatitis b vaccine (recombinant), adjuvanted | Injection | 125428 | 2017-11-09 | ⤷ Subscribe | ⤷ Subscribe |
Mcm Vaccine Company | VAXELIS | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate [meningococcal protein conjugate] and hepatitis b [recombinant] vaccine | Injection | 125563 | 2018-12-21 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |